what changed for me between month 10 and month 18
Question in the title, detail here: what changed for me between month 10 and month 18.
Reference intervals are typically the central 95% of a reference population. By construction one person in twenty falls outside one on any given test without anything being wrong.
Different laboratories use different assay platforms with different calibration. Comparing across labs adds a systematic offset that is invisible on the report.
Time of day, fasting state, hydration and recent exercise all move common markers. Standardising the draw conditions is free and it removes most of the apparent variability.
Happy to answer the boring questions. Those are usually the ones worth asking.
best — the order this archive was captured in
Nobody here can interpret your panel and this comment is not doing so. What a board can usefully do is help you ask better questions of somebody who can.
I would not draw a line through two points, especially when the second was taken at a different time of day.
Careful — that is a question for whoever ordered the panel, and nobody in this thread can answer it responsibly.
That is a non-fasting value and the interval you are comparing it against is a fasting one.
Draw at the same point in the week now, fasting, same lab. The noise dropped enormously once I standardised.
Repeat testing before acting is standard practice for a reason: regression to the mean does a lot of work on single outlying values.
This. Reference ranges are population intervals, not targets, and conflating them causes a lot of unnecessary alarm here.
Is that the same assay, or did the lab change platforms?
Small fix — a reference interval is not a treatment target, and the post above uses them interchangeably.
Correction: that marker is reported in different units by different labs, which explains the tenfold difference you are seeing.
Added ApoB to the panel after a thread here. It told me something the standard lipid panel had been hiding.
Substantial weight loss independently moves lipids, liver enzymes and several other markers. Attributing a change to a compound while losing weight is confounded by design.
ApoB counts atherogenic particles rather than the cholesterol they carry, which is why it can diverge from LDL-C and why it is the addition most worth making.
bring the numbers to someone qualified to read them
Agreed on assay changes. A lab switching platforms between your draws is invisible unless you ask.
ApoB counts atherogenic particles rather than the cholesterol they carry, which is why it can diverge from LDL-C and why it is the addition most worth
Agreed — and standardising the draw conditions is the cheapest improvement available.
Agreed. The trend is the signal. A single value is a snapshot of one morning.
Cosigning on baseline. The panel I regret most is the one I did not take before starting.
ApoB is the one worth adding if you only add one
Same view — ApoB if you add one thing. It answers a question the standard panel only gestures at.
Have you taken this to whoever ordered it?
ask whether the lab changed its assay between your two draws
Yes — same lab, same fasting state, same rough time of day, or the comparison is doing nothing.
Took a baseline the week before starting purely because this board told me to. Best five minutes I have spent on this.
Did anything else change in that window — training, intake, hydration?
one measurement is a point, two is a line, three is a trend
Do you have a baseline from before you started?
Yes. Repeat before you react. Almost every alarming single value I have posted here regressed on the repeat.
- 1Repeat testing before acting is standard practice for a reason: regression…15 comments in this branch · started by u/kenji_kimani
- 2ApoB is the one worth adding if you only add one6 comments in this branch · started by u/lipid_panel_larry